Next Article in Journal
The Approved Live-Attenuated Chikungunya Virus Vaccine (IXCHIQ®) Elicits Cross-Neutralizing Antibody Breadth Extending to Multiple Arthritogenic Alphaviruses Similar to the Antibody Breadth Following Natural Infection
Previous Article in Journal
Lessons from the COVID-19 Pandemic: Promoting Vaccination and Public Health Resilience, a Narrative Review
 
 

Order Article Reprints

Journal: Vaccines, 2024
Volume: 12
Number: 892

Article: Immunogenicity and Safety of a Quadrivalent Influenza Vaccine in Population Aged 3 Years and Older in Chile and the Philippines: A Phase 3, Non-Inferiority, Double-Blind, Randomized Controlled Clinical Trial
Authors: by Wanqi Yang, Pablo A. González, Qianqian Xin, Mari Rose De Los Reyes, Ralph Elvi Villalobos, Charissa Fay Corazon Borja-Tabora, Nancy Nazaire Bermal, Alexis M. Kalergis, Dan Yu, Wenbin Wu, Susan M. Bueno, Liqun Huo, Mario Calvo, QINF Study Group, Gang Zeng and Jing Li
Link: https://www.mdpi.com/2076-393X/12/8/892

MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article and designed to be complimentary to the journal.

Order Cost and Details

Shipping Address

Billing Address

Notes or Comments

Validate and Place Order

The order must be prepaid after it is placed

req denotes required fields.
Back to TopTop